Loading
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (1 ops.)
Latest filing published 29 Jul 2026 for Viking Therapeutics, Inc.. Read the official filing
Filing timeline
BuySaleGreg Zante
Insider track record
Disclosed buys
0
Disclosed sells
1
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
Greg Zante: trading record in brief
Greg Zante, listed as finance chief, appears in our data through filings on Viking Therapeutics, Inc. shares, published by SEC (Form 4). In total, 18 filings cover trades dated from 28 September 2021 to 29 July 2026.
The open-market record consists of 1 sale worth €624k, with no purchase. Other entries cover 12 share grants and 5 option exercises. In 2026 alone, the filings show no purchases and 1 sale.
Most recently, on 29 July 2026, the filings show a share grant in Viking Therapeutics, Inc. Filings reach the SEC (Form 4) feed a median of 2 days after the trade. For comparison, the SEC allows two business days to file a Form 4. Keep in mind that insiders sell for many reasons unrelated to the outlook, from tax bills to estate planning. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.
Companies and markets linked to Greg Zante
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations18 total
31,667 shares0Common Stock, par value $0.00001 per shareSEC:0001193125-26-324447:0
21,217 shares@ US$33.47040.017% mcap56.2% of flowCommon Stock, par value $0.00001 per shareSEC:0001193125-26-324447:1
41,000 shares0Common Stock, par value $0.00001 per shareSEC:0001193125-26-003116:0
11,117 shares0Common Stock, par value $0.00001 per shareSEC:0001193125-25-254298:0
7,667 shares0Common Stock, par value $0.00001 per shareSEC:0000950170-25-093792:0
44,533 shares0Common Stock, par value $0.00001 per shareSEC:0000950170-25-002485:0
12,750 shares@ US$7.7718.4% of flowCommon Stock, par value $0.00001 per shareSEC:0000950170-24-117885:0
6,667 shares0Common Stock, par value $0.00001 per shareSEC:0000950170-24-088538:0
4,249 shares@ US$4.683.7% of flowCommon Stock, par value $0.00001 per shareSEC:0001209191-24-005522:0
31,667 shares0Common Stock, par value $0.00001 per shareSEC:0001209191-24-005116:0
31,667 shares0Common Stock, par value $0.00001 per shareSEC:0001209191-24-004231:0
28,334 shares0Common Stock, par value $0.00001 per shareSEC:0001209191-24-000929:0
7,500 shares@ US$13.0718.0% of flowCommon Stock, par value $0.00001 per shareSEC:0001209191-23-024722:0
3,242 shares@ US$7.774.6% of flowCommon Stock, par value $0.00001 per shareSEC:0001209191-23-024227:0
32,000 shares@ US$8.5250.0% of flowCommon Stock, par value $0.00001 per shareSEC:0001209191-23-022398:0
20,233 shares0Common Stock, par value $0.00001 per shareSEC:0001209191-23-001343:0
3,097 shares@ US$4.881.2% of flowCommon Stock, par value $0.00001 per shareSEC:0001209191-22-001988:0
6,667 shares0Common Stock, par value $0.00001 per shareSEC:0001209191-21-058246:0
18 of 18 declarations
